TINIDAZOLE

TINIDAZOLE was reported 441 times

TINIDAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BEHAVIORAL ADDICTION 1 0.1667
1 BLOOD IRON 1 0.0556
2 PULMONARY ARTERY WALL HYPERTROPHY 1 0.0476
3 POST VACCINATION SYNDROME 1 0.0323
4 CAFFEINE ALLERGY 1 0.0161
5 BARTONELLOSIS 1 0.0152
6 HEPATIC AMOEBIASIS 1 0.0149
7 TRICHOMONIASIS 2 0.0139
8 INTESTINAL FISTULA INFECTION 1 0.0137
9 MIXED INCONTINENCE 1 0.0110
10 CILIARY HYPERAEMIA 1 0.0105
11 AMOEBIC DYSENTERY 1 0.0101
12 PULMONARY HISTOPLASMOSIS 1 0.0100
13 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
14 POLYOMAVIRUS TEST POSITIVE 1 0.0085
15 HYPERVITAMINOSIS D 1 0.0083
16 FIXED DRUG ERUPTION 1 0.0082
17 IRIDOCELE 1 0.0077
18 VISUAL PATHWAY DISORDER 1 0.0062
19 JARISCH-HERXHEIMER REACTION 4 0.0056
20 OSTEOMA 1 0.0056
21 GENERALISED BULLOUS FIXED DRUG ERUPTION 2 0.0054
22 DYSSOMNIA 1 0.0052
23 CERVIX HAEMORRHAGE UTERINE 1 0.0052
24 ROCKY MOUNTAIN SPOTTED FEVER 1 0.0047
25 UTERINE INFLAMMATION 1 0.0046
26 APPENDICEAL ABSCESS 1 0.0041
27 MYOGLOBIN URINE PRESENT 1 0.0041
28 FIXED ERUPTION 7 0.0041
29 ORAL LICHEN PLANUS 2 0.0040
30 BENIGN LUNG NEOPLASM 1 0.0040
31 CORNEAL THINNING 1 0.0039
32 GASTROINTESTINAL FUNGAL INFECTION 2 0.0039
33 THORACIC OUTLET SYNDROME 1 0.0037
34 MENINGITIS TUBERCULOUS 2 0.0036
35 AXONAL NEUROPATHY 3 0.0034
36 VERTEBRAL COLUMN MASS 1 0.0034
37 TEETHING 1 0.0033
38 CORNEAL LESION 1 0.0032
39 BREAST INFLAMMATION 1 0.0032
40 PROSTATIC HAEMORRHAGE 1 0.0031
41 VULVITIS 1 0.0030
42 GIARDIASIS 1 0.0029
43 MENIERE'S DISEASE 1 0.0029
44 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
45 LIVER FUNCTION TEST DECREASED 1 0.0028
46 STOMAL HERNIA 1 0.0027
47 CONGENITAL UMBILICAL HERNIA 1 0.0027
48 BREATH HOLDING 1 0.0026
49 BELLIGERENCE 1 0.0023
50 SEXUALLY TRANSMITTED DISEASE 1 0.0023
51 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
52 TYPE V HYPERLIPIDAEMIA 1 0.0021
53 GENITAL ERYTHEMA 1 0.0020
54 CEREBRAL ARTERY THROMBOSIS 1 0.0019
55 PSEUDOMEMBRANOUS COLITIS 4 0.0018
56 BILIARY DYSKINESIA 3 0.0018
57 SOFT TISSUE SWELLING 1 0.0018
58 GALLBLADDER NON-FUNCTIONING 1 0.0018
59 XEROPHTHALMIA 1 0.0017
60 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
61 MYOPATHY TOXIC 1 0.0016
62 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
63 LYME DISEASE 5 0.0015
64 OPHTHALMIC MIGRAINE 1 0.0014
65 MYELITIS TRANSVERSE 2 0.0014
66 CATAPLEXY 2 0.0014
67 FACIAL DISCOMFORT 1 0.0014
68 ALCOHOL INTOLERANCE 1 0.0014
69 MENINGITIS BACTERIAL 2 0.0014
70 AMNIOTIC CAVITY INFECTION 1 0.0014
71 CUTANEOUS VASCULITIS 5 0.0014
72 TOOTH DISCOLOURATION 4 0.0014
73 FIBROCYSTIC BREAST DISEASE 1 0.0014
74 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
75 WEST NILE VIRAL INFECTION 1 0.0013
76 PERFORATED ULCER 1 0.0013
77 GINGIVAL HYPERTROPHY 2 0.0013
78 BACTERIAL VAGINOSIS 2 0.0013
79 DIARRHOEA INFECTIOUS 1 0.0013
80 RETINAL PIGMENTATION 1 0.0013
81 UTERINE ENLARGEMENT 1 0.0013
82 DYSBIOSIS 1 0.0012
83 METABOLIC SYNDROME 2 0.0012
84 OCULAR VASCULAR DISORDER 1 0.0012
85 SEIZURE LIKE PHENOMENA 2 0.0012
86 CRANIOFACIAL FRACTURE 1 0.0012
87 POUCHITIS 1 0.0012
88 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
89 COLOUR BLINDNESS 1 0.0011
90 NARCOLEPSY 2 0.0011
91 GALLBLADDER INJURY 2 0.0010
92 PSYCHOTIC BEHAVIOUR 1 0.0010
93 CONJUNCTIVAL OEDEMA 1 0.0010
94 THYROID HORMONES INCREASED 1 0.0010
95 NASAL INFLAMMATION 1 0.0009
96 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
97 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
98 PERIRECTAL ABSCESS 1 0.0009
99 HALO VISION 1 0.0009
100 LIP ULCERATION 1 0.0009
101 SECONDARY IMMUNODEFICIENCY 1 0.0008
102 EYE OEDEMA 2 0.0008
103 TACHYARRHYTHMIA 2 0.0008
104 TOXIC ENCEPHALOPATHY 4 0.0008
105 NECROTISING COLITIS 1 0.0008
106 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
107 RETINAL DEGENERATION 1 0.0008
108 ORAL FUNGAL INFECTION 2 0.0007
109 RASH MORBILLIFORM 2 0.0007
110 DISCHARGE 1 0.0007
111 MAST CELL ACTIVATION SYNDROME 1 0.0007
112 INTESTINAL FISTULA 1 0.0007
113 NOROVIRUS INFECTION 1 0.0007
114 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
115 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
116 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
117 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
118 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
119 SUBSTANCE USE 1 0.0006
120 HISTOPLASMOSIS DISSEMINATED 1 0.0006
121 CYSTITIS INTERSTITIAL 1 0.0006
122 PAPILLOMA VIRAL INFECTION 1 0.0006
123 ABDOMINAL TENDERNESS 3 0.0006
124 ARTHROPOD STING 1 0.0006
125 VASCULITIS 7 0.0006
126 EXPOSURE TO CHEMICAL POLLUTION 1 0.0006
127 ACUTE SINUSITIS 1 0.0006
128 TONGUE COATED 1 0.0006
129 NASAL OEDEMA 1 0.0006
130 MONOPARESIS 1 0.0006
131 DERMATITIS BULLOUS 4 0.0006
132 HEPATIC NECROSIS 2 0.0005
133 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
134 ATROPHY 1 0.0005
135 SELF-MEDICATION 2 0.0005
136 PHOTOPSIA 3 0.0005
137 BUNDLE BRANCH BLOCK LEFT 2 0.0005
138 DEREALISATION 1 0.0005
139 PARANOIA 8 0.0005
140 CERVICAL DYSPLASIA 1 0.0005
141 TONGUE DISCOLOURATION 2 0.0005
142 CORNEAL DISORDER 1 0.0005
143 NOSOCOMIAL INFECTION 1 0.0005
144 DRUG ERUPTION 8 0.0005
145 INFECTIOUS MONONUCLEOSIS 1 0.0004
146 PATHOGEN RESISTANCE 4 0.0004
147 LICHENOID KERATOSIS 1 0.0004
148 NEPHROGENIC ANAEMIA 2 0.0004
149 THINKING ABNORMAL 8 0.0004
150 DIARRHOEA HAEMORRHAGIC 4 0.0004
151 DYSMORPHISM 1 0.0004
152 LACUNAR INFARCTION 1 0.0004
153 WRONG DOSE 1 0.0004
154 SYSTEMIC CANDIDA 1 0.0004
155 ABDOMINAL INFECTION 1 0.0004
156 LACTOSE INTOLERANCE 1 0.0004
157 MENOPAUSE 1 0.0004
158 MEDICATION RESIDUE 1 0.0004
159 RETINAL DISORDER 1 0.0004
160 HEPATITIS TOXIC 1 0.0004
161 PERSONALITY DISORDER 1 0.0004
162 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
163 ANAL FISTULA 2 0.0004
164 SKIN DISCOMFORT 1 0.0004
165 ULCERATIVE KERATITIS 1 0.0004
166 VENTRICULAR SEPTAL DEFECT 2 0.0003
167 VITAMIN B12 DECREASED 1 0.0003
168 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
169 CENTRAL VENOUS CATHETERISATION 1 0.0003
170 MEDICAL DEVICE DISCOMFORT 1 0.0003
171 DYSAESTHESIA 1 0.0003
172 DUODENITIS 1 0.0003
173 PRURITUS GENERALISED 7 0.0003
174 EYELIDS PRURITUS 1 0.0003
175 PRE-EXISTING CONDITION IMPROVED 2 0.0003
176 SWELLING OF EYELID 2 0.0003
177 ABDOMINAL ADHESIONS 1 0.0003
178 BILE DUCT STONE 1 0.0003
179 DRUG RESISTANCE 8 0.0003
180 SKIN EROSION 1 0.0003
181 HEPATITIS ACUTE 2 0.0003
182 ORAL CANDIDIASIS 4 0.0003
183 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
184 CHOLECYSTITIS CHRONIC 2 0.0003
185 BLOOD TESTOSTERONE DECREASED 2 0.0003
186 EAR PRURITUS 1 0.0003
187 RASH PUSTULAR 2 0.0003
188 CAROTID ARTERY OCCLUSION 1 0.0003
189 UTERINE LEIOMYOMA 2 0.0003
190 VENTRICULAR ARRHYTHMIA 1 0.0003
191 THROMBOCYTOSIS 1 0.0003
192 MOUTH HAEMORRHAGE 2 0.0003
193 NEURODERMATITIS 1 0.0003
194 BONE DENSITY ABNORMAL 1 0.0003
195 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
196 CONCUSSION 2 0.0003
197 ORAL INFECTION 1 0.0003
198 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
199 HYPERPHAGIA 1 0.0003
200 MUSCLE DISORDER 2 0.0002
201 ANAPHYLACTOID REACTION 1 0.0002
202 MUSCLE FATIGUE 1 0.0002
203 TONGUE DISCOMFORT 1 0.0002
204 UTERINE HAEMORRHAGE 1 0.0002
205 INTERVERTEBRAL DISC DISORDER 1 0.0002
206 SHOULDER OPERATION 1 0.0002
207 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
208 TOOTH INJURY 1 0.0002
209 VULVOVAGINAL DISCOMFORT 1 0.0002
210 BLOOD CREATINE INCREASED 1 0.0002
211 SUSPECTED OFF LABEL USE 1 0.0002
212 VASCULAR DEVICE INFECTION 1 0.0002
213 URINE ABNORMALITY 1 0.0002
214 INJECTION SITE PAPULE 1 0.0002
215 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
216 PERFORMANCE STATUS DECREASED 1 0.0002
217 KIDNEY TRANSPLANT REJECTION 1 0.0002
218 VULVOVAGINAL PAIN 1 0.0002
219 VITAMIN D DEFICIENCY 2 0.0002
220 LIGAMENT SPRAIN 2 0.0002
221 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
222 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
223 HYPERNATRAEMIA 1 0.0002
224 HEPATIC ENZYME ABNORMAL 1 0.0002
225 OVARIAN CYST 2 0.0002
226 DERMATITIS EXFOLIATIVE 1 0.0002
227 NEUROPATHY PERIPHERAL 19 0.0002
228 BRAIN INJURY 2 0.0002
229 ECONOMIC PROBLEM 3 0.0002
230 CACHEXIA 1 0.0002
231 TEMPERATURE INTOLERANCE 2 0.0002
232 FOETAL DEATH 1 0.0002
233 ANHEDONIA 5 0.0002
234 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
235 ANAL ABSCESS 1 0.0002
236 BRUXISM 1 0.0002
237 HIP SURGERY 1 0.0002
238 DEAFNESS UNILATERAL 1 0.0002
239 PANCREATITIS ACUTE 4 0.0002
240 FISTULA 2 0.0002
241 COLECTOMY 1 0.0002
242 CHOLECYSTITIS ACUTE 1 0.0002
243 GRANULOCYTOPENIA 1 0.0002
244 CHOLECYSTECTOMY 2 0.0002
245 VISUAL DISTURBANCE 1 0.0002
246 MOUTH SWELLING 1 0.0002
247 ELECTROLYTE IMBALANCE 2 0.0002
248 ENERGY INCREASED 1 0.0002
249 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
250 ATAXIA 2 0.0002
251 PLEURISY 1 0.0002
252 SINUS HEADACHE 1 0.0002
253 CHOLECYSTITIS 2 0.0002
254 HEARING IMPAIRED 1 0.0002
255 SYNOVITIS 3 0.0002
256 PELVIC PAIN 3 0.0002
257 DRUG DIVERSION 1 0.0002
258 CHOLANGITIS 1 0.0002
259 BACTERIAL INFECTION 3 0.0002
260 SWOLLEN TONGUE 5 0.0002
261 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
262 GENITAL HAEMORRHAGE 2 0.0002
263 CARDIAC FLUTTER 1 0.0002
264 DYSTONIA 3 0.0002
265 POLYP 1 0.0002
266 SOMNAMBULISM 1 0.0002
267 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
268 POST-TRAUMATIC STRESS DISORDER 1 0.0001
269 BREAST MASS 1 0.0001
270 JAUNDICE 4 0.0001
271 ABNORMAL LOSS OF WEIGHT 1 0.0001
272 CROHN'S DISEASE 1 0.0001
273 HAEMATOCHEZIA 8 0.0001
274 AUTOIMMUNE HEPATITIS 1 0.0001
275 MOUTH ULCERATION 3 0.0001
276 PAPULE 1 0.0001
277 LYMPHADENOPATHY 5 0.0001
278 PRODUCT SUPPLY ISSUE 1 0.0001
279 VISUAL FIELD DEFECT 1 0.0001
280 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
281 MAJOR DEPRESSION 1 0.0001
282 MELAENA 3 0.0001
283 SENSITIVE SKIN 1 0.0001
284 CEREBRAL DISORDER 1 0.0001
285 STEVENS-JOHNSON SYNDROME 3 0.0001
286 DYSGEUSIA 10 0.0001
287 SUNBURN 1 0.0001
288 BREAST TENDERNESS 1 0.0001
289 TREATMENT FAILURE 11 0.0001
290 PAROSMIA 1 0.0001
291 TENDON PAIN 1 0.0001
292 OSTEOPENIA 2 0.0001
293 PHARYNGEAL OEDEMA 2 0.0001
294 ANKLE FRACTURE 2 0.0001
295 NERVOUS SYSTEM DISORDER 4 0.0001
296 BONE DENSITY DECREASED 4 0.0001
297 DRUG-INDUCED LIVER INJURY 4 0.0001
298 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
299 RENAL CYST 1 0.0001
300 ENCEPHALOPATHY 3 0.0001
301 PARAESTHESIA 19 0.0001
302 ATRIAL SEPTAL DEFECT 1 0.0001
303 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
304 ABDOMINAL PAIN LOWER 3 0.0001
305 FACE OEDEMA 2 0.0001
306 UTERINE PERFORATION 1 0.0001
307 SKIN HYPERPIGMENTATION 1 0.0001
308 BLOOD MAGNESIUM DECREASED 1 0.0001
309 PSYCHOLOGICAL TRAUMA 1 0.0001
310 MUSCLE STRAIN 1 0.0001
311 PYELONEPHRITIS 1 0.0001
312 LOCAL SWELLING 2 0.0001
313 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
314 ANGIOEDEMA 5 0.0001
315 PURPURA 1 0.0001
316 GALLBLADDER DISORDER 2 0.0001
317 GASTROINTESTINAL INFECTION 1 0.0001
318 MYOSITIS 1 0.0001
319 OROPHARYNGEAL DISCOMFORT 1 0.0001
320 COMPLICATION OF DEVICE REMOVAL 2 0.0001
321 END STAGE RENAL DISEASE 2 0.0001
322 GRAND MAL CONVULSION 1 0.0001
323 CONJUNCTIVITIS 2 0.0001
324 EYE SWELLING 4 0.0001
325 ERYTHEMA MULTIFORME 1 0.0001
326 APPENDICITIS 1 0.0001
327 PHOTOPHOBIA 2 0.0001
328 SPINAL DISORDER 1 0.0001
329 FOOT FRACTURE 2 0.0001
330 ATELECTASIS 1 0.0001
331 SINUS BRADYCARDIA 1 0.0001
332 INFLAMMATORY BOWEL DISEASE 1 0.0001
333 THERAPY CHANGE 1 0.0001
334 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
335 EMBEDDED DEVICE 1 0.0001
336 SALIVARY HYPERSECRETION 1 0.0001
337 VAGINAL DISCHARGE 1 0.0001
338 HYPOTHERMIA 1 0.0001
339 TOOTH ABSCESS 1 0.0001
340 HYPERBILIRUBINAEMIA 1 0.0001
341 PETECHIAE 1 0.0001
342 WEIGHT FLUCTUATION 1 0.0001
343 SCRATCH 1 0.0001
344 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
345 MENSTRUATION DELAYED 1 0.0001
346 MENTAL DISORDER 4 0.0001
347 CHOLELITHIASIS 3 0.0001
348 DENTAL CARIES 1 0.0001
349 TACHYCARDIA 8 0.0001
350 FUNGAL INFECTION 3 0.0001
351 NERVE INJURY 1 0.0001
352 SKIN INFECTION 1 0.0001
353 MYOCARDIAL ISCHAEMIA 1 0.0001
354 HYPOAESTHESIA 13 0.0001
355 PERICARDIAL EFFUSION 2 0.0001
356 EYELID OEDEMA 1 0.0001
357 DYSPHONIA 5 0.0001
358 SPINAL PAIN 1 0.0001
359 URTICARIA 14 0.0001
360 POLYNEUROPATHY 1 0.0001
361 BURSITIS 1 0.0001
362 RESPIRATORY FAILURE 6 0.0001
363 CARDIOMEGALY 1 0.0001
364 CYST 1 0.0001
365 INJECTION SITE DISCOLOURATION 1 0.0001
366 SECRETION DISCHARGE 1 0.0001
367 POISONING 1 0.0001
368 DERMATITIS ALLERGIC 1 0.0001
369 CHRONIC KIDNEY DISEASE 6 0.0001
370 INJECTION SITE IRRITATION 1 0.0001
371 ROTATOR CUFF SYNDROME 1 0.0001
372 ANOREXIA 1 0.0001
373 ANAPHYLACTIC SHOCK 2 0.0001
374 INJECTION SITE INDURATION 1 0.0001
375 DEAFNESS 2 0.0001
376 IMMUNE SYSTEM DISORDER 1 0.0001
377 SARS-COV-2 TEST POSITIVE 1 0.0001
378 DYSMENORRHOEA 1 0.0001
379 ABORTION SPONTANEOUS 3 0.0001
380 RASH PRURITIC 4 0.0001
381 DRUG TOXICITY 1 0.0001
382 SKIN LESION 2 0.0001
383 PROCEDURAL PAIN 2 0.0001
384 MENTAL STATUS CHANGES 2 0.0001
385 CARPAL TUNNEL SYNDROME 1 0.0001
386 BLISTER 4 0.0001
387 INJURY 5 0.0001
388 SEASONAL ALLERGY 1 0.0001
389 ANXIETY 20 0.0001
390 PARAESTHESIA ORAL 1 0.0001
391 DEVICE DISLOCATION 3 0.0001
392 INJECTION SITE HAEMATOMA 1 0.0001
393 FLUSHING 7 0.0001
394 GASTROENTERITIS 1 0.0001
395 MUSCULOSKELETAL STIFFNESS 6 0.0001
396 PRURITUS 26 0.0001
397 BONE LOSS 1 0.0001
398 HYPOAESTHESIA ORAL 1 0.0001
399 APHASIA 2 0.0001
400 LACRIMATION INCREASED 2 0.0001
401 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
402 HIP ARTHROPLASTY 1 0.0001
403 SKIN DISCOLOURATION 3 0.0001
404 DISEASE RECURRENCE 3 0.0001
405 SCIATICA 1 0.0001
406 ABSCESS 1 0.0001
407 HYPOTHYROIDISM 2 0.0001
408 NIGHT SWEATS 2 0.0001
409 SWELLING FACE 4 0.0001
410 MULTIPLE FRACTURES 1 0.0001
411 EYE DISORDER 2 0.0001
412 PYREXIA 21 0.0001
413 PHOTOSENSITIVITY REACTION 1 0.0001
414 DRUG LEVEL INCREASED 1 0.0001
415 TREMOR 10 0.0001
416 CYTOMEGALOVIRUS INFECTION 1 0.0001
417 VIRAL INFECTION 2 0.0001
418 LEUKOPENIA 3 0.0001
419 SKIN DISORDER 2 0.0001
420 BLOOD UREA INCREASED 1 0.0001
421 EYE PRURITUS 2 0.0001
422 CANDIDA INFECTION 1 0.0001
423 HEMIPARESIS 1 0.0001
424 EMOTIONAL DISTRESS 7 0.0001
425 NIGHTMARE 2 0.0001
426 DEVICE DEFECTIVE 1 0.0001
427 EOSINOPHILIA 1 0.0001
428 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
429 GASTROENTERITIS VIRAL 1 0.0001
430 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
431 HYPERHIDROSIS 7 0.0001
432 TOXICITY TO VARIOUS AGENTS 9 0.0001
433 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
434 EYE PAIN 3 0.0001
435 HYPOCALCAEMIA 1 0.0001
436 BLOOD URINE PRESENT 1 0.0001
437 PROTEINURIA 1 0.0001
438 SLEEP APNOEA SYNDROME 1 0.0001
439 EYE IRRITATION 3 0.0001
440 POST PROCEDURAL COMPLICATION 1 0.0001
441 LOWER LIMB FRACTURE 1 0.0001
442 HERNIA 1 0.0001
443 ERUCTATION 1 0.0001
444 PALPITATIONS 6 0.0001
445 SKIN FISSURES 1 0.0001
446 MENORRHAGIA 1 0.0001
447 HAEMATOCRIT DECREASED 1 0.0001
448 BLOOD PRESSURE ABNORMAL 1 0.0001
449 SYNCOPE 5 0.0000
450 TASTE DISORDER 1 0.0000
451 DEVICE BREAKAGE 2 0.0000
452 BONE MARROW FAILURE 1 0.0000
453 VOMITING 23 0.0000
454 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
455 CHEST DISCOMFORT 5 0.0000
456 INSOMNIA 13 0.0000
457 OSTEOPOROSIS 2 0.0000
458 INJECTION SITE WARMTH 1 0.0000
459 RIB FRACTURE 1 0.0000
460 TOOTH LOSS 1 0.0000
461 RASH 21 0.0000
462 RHABDOMYOLYSIS 2 0.0000
463 URINARY TRACT INFECTION 8 0.0000
464 IRRITABLE BOWEL SYNDROME 1 0.0000
465 POOR QUALITY SLEEP 1 0.0000
466 DEVICE EXPULSION 3 0.0000
467 DEEP VEIN THROMBOSIS 3 0.0000
468 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
469 ACUTE KIDNEY INJURY 7 0.0000
470 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
471 TRANSAMINASES INCREASED 1 0.0000
472 RASH MACULO-PAPULAR 1 0.0000
473 HEPATOTOXICITY 1 0.0000
474 COLITIS ULCERATIVE 2 0.0000
475 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
476 CHROMATURIA 1 0.0000
477 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
478 HYPOKALAEMIA 2 0.0000
479 BLOOD CHOLESTEROL INCREASED 2 0.0000
480 CHILLS 5 0.0000
481 PRODUCT PRESCRIBING ERROR 1 0.0000
482 HYPOGLYCAEMIA 2 0.0000
483 FIBROMYALGIA 1 0.0000
484 CEREBRAL INFARCTION 1 0.0000
485 INJECTION SITE URTICARIA 1 0.0000
486 LIVER INJURY 1 0.0000
487 VISUAL IMPAIRMENT 5 0.0000
488 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
489 DRY EYE 2 0.0000
490 HEADACHE 25 0.0000
491 HAEMATEMESIS 1 0.0000
492 HEPATITIS 1 0.0000
493 SINUSITIS 4 0.0000
494 RASH GENERALISED 1 0.0000
495 MUSCULOSKELETAL PAIN 2 0.0000
496 MUSCLE SPASMS 7 0.0000
497 GASTRITIS 1 0.0000
498 DERMATITIS ATOPIC 2 0.0000
499 DRUG INTERACTION 6 0.0000
500 EAR INFECTION 1 0.0000
501 MENSTRUATION IRREGULAR 1 0.0000
502 BLOOD BILIRUBIN INCREASED 1 0.0000
503 THROAT TIGHTNESS 1 0.0000
504 MOOD ALTERED 1 0.0000
505 CONDITION AGGRAVATED 11 0.0000
506 MEDICATION ERROR 2 0.0000
507 FEELING COLD 1 0.0000
508 DIARRHOEA 23 0.0000
509 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
510 NAUSEA 28 0.0000
511 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
512 RED BLOOD CELL COUNT DECREASED 1 0.0000
513 ANGINA PECTORIS 1 0.0000
514 PRODUCT SUBSTITUTION ISSUE 2 0.0000
515 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
516 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
517 INFECTION 5 0.0000
518 DYSSTASIA 1 0.0000
519 NASAL CONGESTION 2 0.0000
520 ACUTE MYOCARDIAL INFARCTION 1 0.0000
521 URINARY INCONTINENCE 1 0.0000
522 RENAL INJURY 1 0.0000
523 DEVICE ISSUE 3 0.0000
524 HEPATIC FAILURE 1 0.0000
525 JOINT SWELLING 4 0.0000
526 PLEURAL EFFUSION 2 0.0000
527 FEELING HOT 2 0.0000
528 DRUG ADMINISTRATION ERROR 1 0.0000
529 LIMB DISCOMFORT 1 0.0000
530 SWELLING 3 0.0000
531 HEAD INJURY 1 0.0000
532 PULMONARY EMBOLISM 3 0.0000
533 MIGRAINE 3 0.0000
534 MOOD SWINGS 1 0.0000
535 METABOLIC ACIDOSIS 1 0.0000
536 MOVEMENT DISORDER 1 0.0000
537 DEPRESSION 7 0.0000
538 OSTEONECROSIS 1 0.0000
539 HEART RATE INCREASED 3 0.0000
540 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
541 RENAL FAILURE 4 0.0000
542 VISUAL ACUITY REDUCED 1 0.0000
543 ABDOMINAL PAIN 7 0.0000
544 EXPIRED PRODUCT ADMINISTERED 1 0.0000
545 DIZZINESS 15 0.0000
546 LIP SWELLING 1 0.0000
547 DEHYDRATION 4 0.0000
548 URINARY RETENTION 1 0.0000
549 OFF LABEL USE 26 0.0000
550 MALAISE 13 0.0000
551 ANGER 1 0.0000
552 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
553 ASTHENIA 11 0.0000
554 FEELING ABNORMAL 7 0.0000
555 DELIRIUM 1 0.0000
556 RASH MACULAR 1 0.0000
557 BURNING SENSATION 2 0.0000
558 HYPERKALAEMIA 1 0.0000
559 HEART RATE DECREASED 1 0.0000
560 SLEEP DISORDER 2 0.0000
561 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
562 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
563 CEREBRAL HAEMORRHAGE 1 0.0000
564 SKIN BURNING SENSATION 2 0.0000
565 OVERDOSE 6 0.0000
566 MYELOSUPPRESSION 1 0.0000
567 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
568 PAIN 17 0.0000
569 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
570 CRYING 1 0.0000
571 HYPERGLYCAEMIA 1 0.0000
572 PANIC ATTACK 1 0.0000
573 HYPERSENSITIVITY 5 0.0000
574 HEPATIC FUNCTION ABNORMAL 1 0.0000
575 DYSARTHRIA 1 0.0000
576 INTESTINAL OBSTRUCTION 1 0.0000
577 UNEVALUABLE EVENT 2 0.0000
578 RHEUMATOID ARTHRITIS 3 0.0000
579 COLITIS 1 0.0000
580 ACNE 2 0.0000
581 GAIT DISTURBANCE 5 0.0000
582 INJECTION SITE SWELLING 2 0.0000
583 HOSPITALISATION 4 0.0000
584 BACK PAIN 6 0.0000
585 PLASMA CELL MYELOMA 1 0.0000
586 ABNORMAL BEHAVIOUR 1 0.0000
587 DISORIENTATION 1 0.0000
588 INJECTION SITE HAEMORRHAGE 2 0.0000
589 DRUG INEFFECTIVE 33 0.0000
590 DYSPNOEA 14 0.0000
591 PNEUMONIA 8 0.0000
592 EXTRA DOSE ADMINISTERED 1 0.0000
593 DRY MOUTH 2 0.0000
594 NEUTROPHIL COUNT DECREASED 1 0.0000
595 ERYTHEMA 5 0.0000
596 ABDOMINAL PAIN UPPER 5 0.0000
597 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
598 ROAD TRAFFIC ACCIDENT 1 0.0000
599 WITHDRAWAL SYNDROME 1 0.0000
600 SKIN EXFOLIATION 2 0.0000
601 RENAL FAILURE ACUTE 1 0.0000
602 VAGINAL HAEMORRHAGE 1 0.0000
603 SEPTIC SHOCK 1 0.0000
604 INTENTIONAL PRODUCT MISUSE 2 0.0000
605 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
606 PULMONARY OEDEMA 1 0.0000
607 THROAT IRRITATION 1 0.0000
608 ADVERSE DRUG REACTION 2 0.0000
609 THERAPY NON-RESPONDER 1 0.0000
610 PRODUCT QUALITY ISSUE 3 0.0000
611 VISION BLURRED 3 0.0000
612 MEMORY IMPAIRMENT 3 0.0000
613 NEPHROLITHIASIS 1 0.0000
614 TINNITUS 1 0.0000
615 ARTHRALGIA 9 0.0000
616 RENAL DISORDER 1 0.0000
617 OCULAR HYPERAEMIA 1 0.0000
618 RASH ERYTHEMATOUS 1 0.0000
619 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
620 CONTUSION 2 0.0000
621 DRUG INTOLERANCE 2 0.0000
622 INTERSTITIAL LUNG DISEASE 1 0.0000
623 ALOPECIA 4 0.0000
624 DYSPEPSIA 2 0.0000
625 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
626 BLOOD PRESSURE INCREASED 3 0.0000
627 ILLNESS 2 0.0000
628 INFLAMMATION 1 0.0000
629 ABDOMINAL DISTENSION 2 0.0000
630 NERVOUSNESS 1 0.0000
631 ECZEMA 1 0.0000
632 SPEECH DISORDER 1 0.0000
633 OEDEMA 1 0.0000
634 TREATMENT NONCOMPLIANCE 1 0.0000
635 DEPENDENCE 1 0.0000
636 DRUG DOSE OMISSION 3 0.0000
637 ANAPHYLACTIC REACTION 1 0.0000
638 ARTHROPATHY 1 0.0000
639 SEPSIS 2 0.0000
640 NECK PAIN 1 0.0000
641 WEIGHT INCREASED 4 0.0000
642 OXYGEN SATURATION DECREASED 1 0.0000
643 HYPONATRAEMIA 1 0.0000
644 MYALGIA 3 0.0000
645 FLATULENCE 1 0.0000
646 INCORRECT DOSE ADMINISTERED 4 0.0000
647 CONVULSION 1 0.0000
648 HERPES ZOSTER 1 0.0000
649 DECREASED APPETITE 4 0.0000
650 BONE PAIN 1 0.0000
651 SURGERY 1 0.0000
652 CATARACT 1 0.0000
653 IRRITABILITY 1 0.0000
654 STOMATITIS 1 0.0000
655 ILL-DEFINED DISORDER 1 0.0000
656 VERTIGO 1 0.0000
657 NASOPHARYNGITIS 3 0.0000
658 CHEST PAIN 3 0.0000
659 INJECTION SITE ERYTHEMA 2 0.0000
660 EXPOSURE DURING PREGNANCY 1 0.0000
661 PRODUCT USE ISSUE 3 0.0000
662 ANAEMIA 3 0.0000
663 INTENTIONAL OVERDOSE 1 0.0000
664 AMNESIA 1 0.0000
665 BLOOD CREATININE INCREASED 1 0.0000
666 DEVICE DIFFICULT TO USE 1 0.0000
667 BLOOD PRESSURE DECREASED 1 0.0000
668 SOMNOLENCE 3 0.0000
669 FATIGUE 11 0.0000
670 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
671 THERAPY INTERRUPTED 1 0.0000
672 UNDERDOSE 1 0.0000
673 AGITATION 1 0.0000
674 PRODUCT DOSE OMISSION ISSUE 4 0.0000
675 EPISTAXIS 1 0.0000
676 PERIPHERAL SWELLING 2 0.0000
677 INJECTION SITE BRUISING 1 0.0000
678 CARDIAC FAILURE 1 0.0000
679 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
680 CEREBROVASCULAR ACCIDENT 2 0.0000
681 PRODUCT STORAGE ERROR 1 0.0000
682 COVID-19 2 0.0000
683 GASTROINTESTINAL DISORDER 1 0.0000
684 NO ADVERSE EVENT 2 0.0000
685 DYSPHAGIA 1 0.0000
686 ATRIAL FIBRILLATION 1 0.0000
687 INJECTION SITE PAIN 3 0.0000
688 HAEMOGLOBIN DECREASED 1 0.0000
689 HAEMORRHAGE 1 0.0000
690 HYPERTENSION 2 0.0000
691 PLATELET COUNT DECREASED 1 0.0000
692 CONSTIPATION 2 0.0000
693 FALL 3 0.0000
694 SEIZURE 1 0.0000
695 OEDEMA PERIPHERAL 1 0.0000
696 DEATH 7 0.0000
697 LOSS OF CONSCIOUSNESS 1 0.0000
698 DRY SKIN 1 0.0000
699 NEUTROPENIA 1 0.0000
700 WEIGHT DECREASED 2 0.0000
701 PAIN IN EXTREMITY 2 0.0000
702 CONFUSIONAL STATE 1 0.0000
703 MYOCARDIAL INFARCTION 1 0.0000
704 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
705 BLOOD GLUCOSE INCREASED 1 0.0000
706 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000